© 2021 MJH Life Sciences and Patient Care Online. All rights reserved.
© 2021 MJH Life Sciences™ and Patient Care Online. All rights reserved.
September 07, 2016
Results unequivocally support early, aggressive, and sustained risk factor control in patients with complicated type 2 diabetes.
August 25, 2016
The renal protective effects seen with the SGLT2 inhibitor canogliflizin may be independent of glycemic control, suggest authors of a new post-hoc analysis.